FindTrial
Sign In

AI-based decision-making tool for stratified treatment of pTNM Stage III colorectal cancer in the low-risk group

AI-based decision-making tool for stratified treatment of pTNM Stage III colorectal cancer in the low-risk group

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096608
Enrollment
Unknown
Registered
2025-01-26
Start date
2025-02-05
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pTNM III CRC

Interventions

Observation group:None

Sponsors

Department of General Surgery, Division of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.The confirmed age is 18 years or older. 2.Patients with pTNM stage III colorectal cancer confirmed by tissue biopsy. 3.Patient's informed consent has been obtained.

Exclusion criteria

Exclusion criteria: Has other malignancies (excluding those that have been completely cured and no longer affect the current study), or has severe mental illness that prevents reasonable assessment.

Design outcomes

Primary

MeasureTime frame
Overall survival,OS;—

Secondary

MeasureTime frame
Disease-free survival, DFS;—

Countries

China

Contacts

Public ContactWang Xiaodong

West China Hospital, Sichuan University

wangxiaodong@wchscu.cn+86 189 8060 6164

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026